Gianluigi Forloni - Concepedia

Author

Gianluigi Forloni

Mario Negri Institute for Pharmacological Research ORCID

Also Known As

Chiara Fenoglio, Dan Rujescu, Forloni Gianluigi, Forloni, G, Forloni, G., Forloni, Gianluigi, G FORLONI, G Forloni, G L Forloni, G. FORLONI

642

Publications

23K

Citations

H-Index

302

Concepts

All Affiliations

Mario Negri Institute for Pharmacological Research University of Milan Istituti di Ricovero e Cura a Carattere Scientifico Fondazione IRCCS Istituto Neurologico Carlo Besta Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

About

Gianluigi Forloni is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	60	163	10.2K
2	Engineering	20	21	1.5K
3	Natural Sciences	15	17	1.2K
4	Health Sciences	13	17	521
5	Education	1	1	23

Gianluigi Forloni

290

Publications

18.8K

Citations

H-Index

Page 1

	Year	Citations
Neurotoxicity of a prion protein fragment Gianluigi Forloni, Nadia Angeretti, Roberto Chiesa, Nature Creutzfeldt-jakob DiseasePrion Protein FragmentPrion DiseaseNeuroscienceNeuropathology	1993	940
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein Claudia Balducci, Marten Beeg, Matteo Stravalaci, Proceedings of the National Academy of Sciences	2010	457
Frontotemporal dementia and its subtypes: a genome-wide association study Raffaele Ferrari, Dena G. Hernandez, Michael A. Nalls, The Lancet Neurology Alzheimer's DiseaseDementiaFrontotemporal DementiaNeurologyNeurodegeneration	2014	394
Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects Roberta Borghi, Roberta Marchese, Alessandro Negro, Neuroscience Letters Neurodegenerative DiseasesFull Length α-SynucleinNeurobiology Of DiseaseCerebrospinal FluidParkinson Disease	2000	363
Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35 Gianluigi Forloni, Roberto Chiesa, Simona Smiroldo, Neuroreport	1993	341
Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia Pierluigi Quadri, C. Fragiacomo, Rita Pezzati, American Journal of Clinical Nutrition	2004	337
The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptide Diego Albani, Letizia Polito, Sara Batelli, Journal of Neurochemistry	2009	258
Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1 Gianluigi Forloni, Federica Demicheli, Sussana Giorgi, Molecular Brain Research InflammationNeurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceImmunology	1992	253
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Fabrizio Tagliavini, Frances Prelli, Laura Verga, Proceedings of the National Academy of Sciences	1993	240
<i>TMEM106B</i> regulates progranulin levels and the penetrance of FTLD in <i>GRN</i> mutation carriers NiCole A. Finch, Minerva M. Carrasquillo, Matthew Baker, Neurology	2010	239

Page 1